arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

QuidelOrtho Corporation

QDEL Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances
$13.48
▼ -5.1% Today
as of Oct 22, 16:51 ET
Last 30 days +21.22% Sep 14 → Oct 22
$10.03 $11.15 $12.28 $13.40 $14.52 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$14.01
High
$14.63
Low
$13.27
Volume
$2M
Avg Vol
$2M
Mkt Cap
$844M
P/E (TTM)
—
Beta
—
52w High
$35.58
52w Low
$9.92
Div Yield
—
Shares Out
$68M

Recent Press Releases & News last 60 days · 7 items

Oct 20 · 12:00 PR PR Newswire
QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026
Oct 16 · 20:51 StockStory
Novavax, Ocular Therapeutix, and QuidelOrtho Shares Plummet, What You Need To Know
Oct 15 · 22:10 PR PR Newswire
QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
▸ Show all 7 press releases & news Free account →

QDEL earnings at a glance

QuidelOrtho Corporation (QDEL) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. Analysts expect earnings per share of $0.18, compared with $0.80 in the same quarter last year (-78%). The options market is pricing a move of about ±12.0% after the report, a range of roughly $11.86 to $15.10 from today's $13.48. Over its last 6 reports the stock rose the next day 1 time and fell 5, moving ±18.8% on average; after the most recent report on Aug 6, 2026 it moved -24.7%. That means options currently expect less movement than QDEL has typically delivered. QDEL beat the consensus EPS estimate in 4 of its last 5 reported quarters. Implied volatility is currently 102%. The share price of $13.48 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$9.92
$36
14% of range
Avg surprise (last 5)
+81.6%
Avg reaction (last 6)
-5.1%
17% positive
Latest IV / EM
102%
EM ±12.0% · $13 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-25.50$-18.93$-12.35$-5.77$0.80 Actual $0.73Actual $-0.80Actual $-0.19Actual $-25.50Actual $-2.20Actual $-0.30Actual $0.74Est $0.57Actual $0.12Actual $0.80Est $0.51Actual $0.46Est $0.43Actual $-0.04Est $0.37Actual $0.13Est $-0.04 AprJulOctMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-733M$-359M$15M$389M$763M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Aug 6, 2026Jun/2026 $0.13 $-0.04 +425.0% -133.3% -24.7% earnings
Tue May 5, 2026Mar/2026 $-0.04 $0.37 -110.8% -105.4% -6.0% earnings
Wed Feb 11, 20268K 2026-02-11 $0.46 $0.43 +7.0% — -17.6% earnings
Wed Nov 5, 2025Sep/2025 $0.80 $0.51 +56.9% — -22.3% earnings
Tue Aug 5, 2025Jun/2025 $0.12 — — — -1.0% earnings
Wed May 7, 2025Mar/2025 $0.74 $0.57 +29.8% — +41.0% earnings
Sun Sep 29, 2024Sep 2024 $-0.30 — — — — financials
Sun Jun 30, 2024Jun 2024 $-2.20 — — — — financials
Sun Mar 31, 2024Mar 2024 $-25.50 — — — — financials
Sun Oct 1, 2023Oct 2023 $-0.19 — — — — financials
Sun Jul 2, 2023Jul 2023 $-0.80 — — — — financials
Sun Apr 2, 2023Apr 2023 $0.73 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER $0.18$0.80 -77.5%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$631M$620M—$700M$614M$693M—$727M
Cost of revenue————————
Gross profit————————
Operating income$-22M$-32M—$-705M$-181M$33M—$15M
Net income$-93M$-92M—$-733M$-255M$-13M—$-20M
EPS (diluted)$-1.36$-1.35—$-10.78$-3.77$-0.19—$-0.30

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$123M$140M$170M$98M$152M$127M$98M$144M
Inventory$619M$612M$578M$614M$579M$563M$534M$577M
Total current assets$1.38B$1.38B$1.45B$1.37B$1.28B$1.26B$1.22B$1.41B
Total assets$5.72B$5.63B$5.77B$5.68B$6.38B$6.46B$6.42B$6.80B
Long-term debt————————
Total liabilities$3.94B$3.78B$3.85B$3.64B$3.59B$3.46B$3.44B$3.61B
Total equity$1.77B$1.85B$1.92B$2.04B$2.79B$3.00B$2.98B$3.19B

Implied volatility — last 90 days

46%145%244%343%442% Jun 07 — IV 123% · EM ±17.1%Jun 08 — IV 113% · EM ±14.9%Jun 09 — IV 113% · EM ±14.2%Jun 10 — IV 182% · EM ±21.5%Jun 11 — IV 173% · EM ±19.2%Jun 12 — IV 106% · EM ±10.8%Jun 15 — IV 116% · EM ±8.4%Jun 16 — IV 129% · EM ±7.6%Jun 17 — IV 378% · EM ±15.8%Jun 19 — IV 90% · EM ±19.9%Jun 22 — IV 89% · EM ±18.6%Jun 23 — IV 108% · EM ±22.0%Jun 24 — IV 98% · EM ±19.7%Jun 25 — IV 96% · EM ±18.9%Jun 26 — IV 99% · EM ±18.9%Jun 29 — IV 106% · EM ±18.8%Jun 30 — IV 85% · EM ±14.7%Jul 01 — IV 95% · EM ±16.0%Jul 02 — IV 86% · EM ±13.8%Jul 03 — IV 89% · EM ±13.8%Jul 06 — IV 109% · EM ±15.1%Jul 07 — IV 125% · EM ±16.5%Jul 08 — IV 141% · EM ±17.7%Jul 09 — IV 85% · EM ±10.0%Jul 10 — IV 119% · EM ±13.1%Jul 13 — IV 114% · EM ±9.5%Jul 14 — IV 125% · EM ±9.1%Jul 20 — IV 103% · EM ±24.3%Jul 21 — IV 97% · EM ±22.5%Jul 22 — IV 126% · EM ±28.7%Jul 23 — IV 108% · EM ±24.3%Jul 24 — IV 172% · EM ±38.0%Jul 27 — IV 114% · EM ±23.8%Jul 28 — IV 115% · EM ±23.5%Jul 29 — IV 126% · EM ±25.3%Jul 30 — IV 113% · EM ±22.2%Jul 31 — IV 112% · EM ±21.5%Aug 03 — IV 116% · EM ±20.5%Aug 04 — IV 120% · EM ±20.6%Aug 05 — IV 143% · EM ±23.8%Aug 06 — IV 133% · EM ±21.5%Aug 07 — IV 96% · EM ±15.1%Aug 10 — IV 89% · EM ±12.4%Aug 11 — IV 154% · EM ±20.4%Aug 12 — IV 87% · EM ±11.0%Aug 13 — IV 87% · EM ±10.3%Aug 14 — IV 111% · EM ±12.2%Aug 17 — IV 107% · EM ±8.9%Aug 18 — IV 360% · EM ±26.1%Aug 19 — IV 325% · EM ±19.2%Aug 20 — IV 97% · EM ±4.0%Aug 24 — IV 78% · EM ±16.2%Aug 25 — IV 73% · EM ±14.9%Aug 26 — IV 70% · EM ±14.1%Aug 27 — IV 67% · EM ±13.1%Aug 28 — IV 55% · EM ±10.5%Aug 31 — IV 73% · EM ±13.0%Sep 01 — IV 163% · EM ±28.0%Sep 02 — IV 71% · EM ±11.8%Sep 03 — IV 85% · EM ±13.8%Sep 04 — IV 73% · EM ±11.5%Sep 07 — IV 83% · EM ±11.5%Sep 08 — IV 89% · EM ±11.8%Sep 09 — IV 85% · EM ±10.7%Sep 10 — IV 71% · EM ±8.4%Sep 11 — IV 106% · EM ±11.7%Sep 14 — IV 237% · EM ±19.8%Sep 15 — IV 293% · EM ±21.2%Sep 17 — IV 443% · EM ±18.5%Sep 21 — IV 78% · EM ±16.3%Sep 22 — IV 82% · EM ±16.7%Sep 23 — IV 88% · EM ±17.6%Sep 24 — IV 103% · EM ±20.1%Sep 25 — IV 76% · EM ±14.6%Sep 28 — IV 82% · EM ±14.5%Sep 29 — IV 47% · EM ±8.0%Sep 30 — IV 111% · EM ±18.5%Oct 01 — IV 88% · EM ±14.2%Oct 02 — IV 62% · EM ±9.8%Oct 06 — IV 137% · EM ±18.1%Oct 07 — IV 104% · EM ±13.0%Oct 08 — IV 102% · EM ±12.0%

Sector peers

ACHV
Achieve Life Sciences, Inc.
$745M $6.50-0.1%
TKNO
Alpha Teknova, Inc.
$468M $6.15-16.8%
MYGN
Myriad Genetics, Inc.
$409M $5.76+4.0%
IMDX
Insight Molecular Diagnostics Inc.
$114M $2.84-6.3%
ICCC
ImmuCell Corporation
$87M $10.44-0.1%
NTLA
Intellia Therapeutics, Inc.
$1.6B $11.16-5.7%

QDEL earnings FAQ

When is QDEL's next earnings date?

QuidelOrtho Corporation is expected to report on November 4, 2026.

What is QDEL's expected move for earnings?

Options currently price a move of about ±12.0%, or $1.62 per share either way from $13.48.

How does QDEL stock usually react to earnings?

Across the last 6 reports the average next-day move was ±18.8%, up 1 times and down 5 times.

What EPS are analysts expecting from QuidelOrtho Corporation?

The consensus estimate is $0.18 per share, versus $0.80 a year ago.

What is QDEL's implied volatility?

QDEL's at-the-money implied volatility is about 102% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in